Stonebridge Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-60
| Closed | -$7.34K | – | 488 |
|
|
2023
Q3 | $7.34K | Sell |
60
-5
| -8% | -$611 | ﹤0.01% | 653 |
|
|
2023
Q2 | $8.25K | Buy |
65
+5
| +8% | +$635 | ﹤0.01% | 639 |
|
|
2023
Q1 | $7.75K | Hold |
60
| – | – | ﹤0.01% | 651 |
|
|
2022
Q4 | $7.88K | Hold |
60
| – | – | ﹤0.01% | 641 |
|
|
2022
Q3 | $7K | Sell |
60
-50
| -45% | -$5.83K | ﹤0.01% | 639 |
|
|
2022
Q2 | $13K | Hold |
110
| – | – | ﹤0.01% | 552 |
|
|
2022
Q1 | $14K | Hold |
110
| – | – | ﹤0.01% | 601 |
|
|
2021
Q4 | $17K | Hold |
110
| – | – | ﹤0.01% | 535 |
|
|
2021
Q3 | $18K | Sell |
110
-94
| -46% | -$15.4K | ﹤0.01% | 515 |
|
|
2021
Q2 | $33K | Buy |
204
+144
| +240% | +$23.3K | ﹤0.01% | 544 |
|
|
2021
Q1 | $9K | Buy |
+60
| New | +$9K | ﹤0.01% | 652 |
|
|
2020
Q3 | – | Sell |
-102
| Closed | -$14K | – | 411 |
|
|
2020
Q2 | $14K | Hold |
102
| – | – | ﹤0.01% | 449 |
|
|
2020
Q1 | $11K | Hold |
102
| – | – | ﹤0.01% | 465 |
|
|
2019
Q4 | $12K | Buy |
102
+42
| +70% | +$4.94K | ﹤0.01% | 530 |
|
|
2019
Q3 | $6K | Hold |
60
| – | – | ﹤0.01% | 596 |
|
|
2019
Q2 | $7K | Buy |
+60
| New | +$7K | ﹤0.01% | 622 |
|